Vaccitech plc Insider Trades

VACC

Track insider trading activity from Vaccitech plc executives and directors. See which insiders are buying and selling VACC stock.

Trades Last 12 Months

VACC Price

All Insider Trades for Vaccitech plc

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Griffiths Graham Chief Business Officer
Holding Value $483k 96,500 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$483k 96,500 shares
$5.00
$5.00
Brown Gemma Chief Financial Officer
Holding Value $965k 193,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$965k 193,000 shares
$5.00
$5.00
Pelletier Nadege Chief Scientific Officer
Holding Value $525k 105,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$525k 105,000 shares
$5.00
$5.00
Enright William Chief Executive Officer
Holding Value $2.22M 443,981 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.22M 443,981 shares
$5.00
$5.00
Scheeren Joseph Director
Holding Value $115k 23,000 shares
Last Trade
Jun 26, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.4k 10,000 shares
$2.44
$5.00
Wright Robin Director
Holding Value $241k 48,256 shares
Last Trade
May 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$36.6k 13,750 shares
$2.66
$5.00
Dawes Karen A Director
Holding Value $96k 19,197 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 19,197 shares
$2.27
$5.00
Hammacher Alex Director
Holding Value $96k 19,197 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 19,197 shares
$2.27
$5.00
Morgon Pierre A. Director
Holding Value $96k 19,197 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 19,197 shares
$2.27
$5.00
Phillips Anne M. Director
Holding Value $96k 19,197 shares
Last Trade
May 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 19,197 shares
$2.27
$5.00
Ellis Christopher Chief Operating Officer
Holding Value $525k 105,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 105,000 shares
$2.40
$5.00
Evans Thomas George Fmr Chief Scientific Officer
Holding Value $625k 125,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 125,000 shares
$2.40
$5.00
Marshall Margaret Chief Medical Officer
Holding Value $300k 60,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 60,000 shares
$2.40
$5.00
Holding Value $26M 5,197,349 shares
Last Trade
Sep 30, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$13.1M 4,108,752 shares
$3.20
$5.00
Holding Value $0 0 shares
Last Trade
Sep 30, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$13.1M 4,108,752 shares
$3.20
$5.00
Egorov Georgy Chief Financial Officer
Holding Value $570k 114,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 114,000 shares
$11.12
$5.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up